The DETECT Initiative in Early Alzheimer’s Disease: Optimizing Collaboration and Multidisciplinary Care to Facilitate Timely Diagnosis
Released On
March 31, 2023
Expires On
March 31, 2024
Media Type
Internet
Completion Time
60 minutes
Specialty
Primary Care Clinicians, Neurologists, Geriatricians, Geriatric Psychologists, Psychiatrists, Pharmacists
Topic(s)
Alzheimer's Disease
This activity is provided by Med Learning Group.
This activity is co-provided by AMEDCO.
This activity is supported by an educational grant from Lilly.
Credit Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit™
- Nurses — 1.0 Contact Hour
- Pharmacists and Pharmacy Technicians (ACPE) - maximum of 1.00 knowledge-based CPE contact hour
Nursing and Pharmacy learners, view this Learner Notification prior to starting this activity.
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This activity is designed to meet the educational needs of U.S.-based community healthcare providers who care for patients with AD, including primary care clinicians, neurologists, geriatricians, geriatric psychologists, psychiatrists, pharmacists, and managed care professionals.
Program Overview
The DETECT Immersive Simulation experience provides up-to-date information on the diagnosis and management of mild cognitive impairment and Alzheimer’s disease (AD) targeted to specific specialties. The program uses a case-based, interactive format designed to enhance clinician knowledge and improve their confidence in treating this population.
Learning Objectives
Upon completion of this activity, attendees should be able to:
- Evaluate the burden of Alzheimer’s disease (AD), including the process of prolonged decline in cognitive function
- Provide an accurate and timely diagnosis of AD to allow for early disease management and/or referral to specialists
- Use cognitive assessments, biomarkers, and imaging in distinguishing between normal aging and cognitive impairment
- Select and use the best therapeutic options for patients with AD based on up-to-date clinical data on established and emerging disease-modifying therapies
- Employ best practices for multidisciplinary care coordination, workflows, and best practices for referral of patients
Faculty
Liana Apostolova, MD, MSc, FAAN
Indiana University Distinguished Professor
Barbara and Peer Baekgaard Professor of Alzheimer’s Disease Research
Professor in Neurology, Radiology, Medical and Molecular Genetics
Indiana University School of Medicine
Department of Neurology
Indianapolis, IN
Geoffrey C. Wall, PharmD, FCCP, BCPS
John R. Ellis Distinguished Chair of Pharmacy Practice
Professor of Clinical Sciences
Director, Drake Drug Information Center
Drake University College of Pharmacy and Health Sciences
Internal Medicine Clinical Pharmacist
Iowa Methodist Medical Center
Des Moines, IA
Accreditation Statement
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and MED Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team
Physician Credit Designation
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 1.00 ANCC contact hours.
Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of 1.00 knowledge-based CPE contact hours.
Disclosure Policy Statement
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Disclosures of Conflicts of Interest
- Liana Apostolova, MD, MSc, FAAN
- Consulting Fees: Biogen, IQVIA, National Institutes of Health, Lilly, Eisai, GE HealthCare, Roche Diagnostics, Genentech, Corium, and Siemens
- Contracted for Research: Avid Radiopharmaceuticals, Life Molecular Imaging, and Roche
- Ownership Interest: Cassava Sciences
- Geoffrey C. Wall, PharmD, FCCP, BCPS
- Nothing to disclose
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer-reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer-reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME/CE activity:
Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Nicole Longo, DO, FACOI, Vice President of Med/Sci Services & Learner Engagement for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
Jessica McMullen, MPH, Program Manager for Med Learning Group, has nothing to disclose.
Daniel Dasilva, Accreditation and Outcomes Coordinator, has nothing to disclose.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
Method of Participation
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:
- Read the CME/CNE information and faculty disclosures
- Participate in the enduring activity
- Complete the online post-test and evaluation
Participants will receive their certificate as a downloadable file.
Disclaimer
Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy.
If you need further assistance obtaining your CNE or Pharmacy credit, please email: certificate@AmedcoEmail.com.
Americans With Disabilities Act
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at info@medlearninggroup.com.
Copyright© 2023 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
